In HR+/HER2+ breast cancer, tumor cells from patients achieving pCR demonstrate spatial clustering characterized by high connectivity and short edge lengths, concurrent with a molecular subtype shift toward HER2-LUM (low hormone receptor expression). Here, ERBB2 is linked to breast cancer.